Lista de obras - Raj Vuppalanchi - Dominio Público Uruguay

A not-so-sweet diagnosis: secondary biliary cirrhosis from a "lollipop" stone

artículo científico publicado en 2015

A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis

scientific article published on 09 March 2020

Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity

artículo científico publicado en 2007

Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.

artículo científico publicado en 2010

Clinical and histologic features of azithromycin-induced liver injury

artículo científico publicado en 2014

Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide

artículo científico publicado en 2012

Clinical and histopathologic features of fluoroquinolone-induced liver injury.

artículo científico publicado en 2011

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

artículo científico publicado en 2011

Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Non-alcoholic Fatty Liver Disease Based on United States Health Care System

artículo científico publicado en 2020

De novo malignancy post-liver transplantation: a single center, population controlled study.

artículo científico publicado en 2013

Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage

scientific article published on 04 January 2019

Drug-Induced Liver Injury.

artículo científico publicado en 2015

Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt

artículo científico publicado en 2011

Drug-induced nodular regenerative hyperplasia.

artículo científico

Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.

artículo científico publicado en 2010

Dyslipidemia in patients with nonalcoholic fatty liver disease.

artículo científico publicado en 2012

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

scientific article published on 05 December 2019

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

artículo científico publicado en 2008

Endoscopic Sedation in Roux-en-Y Gastric Bypass

artículo científico publicado en 2015

Endoscopic therapy with 2-octyl-cyanoacrylate for the treatment of gastric varices.

artículo científico

Erratum to: Severe Drug-Induced Skin and Liver Injury from Rivaroxaban

artículo científico publicado en 2015

Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.

artículo científico publicado en 2015

Febuxostat-induced acute liver injury.

artículo científico

Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease

artículo científico publicado en 2011

HIV-1 coinfection profoundly alters intrahepatic chemokine but not inflammatory cytokine profiles in HCV-infected subjects

artículo científico publicado en 2014

HLA-B*35:01 and Green Tea Induced Liver Injury

artículo científico publicado en 2020

Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.

artículo científico publicado en 2011

Herbal dietary supplement associated hepatotoxicity: an upcoming workshop and need for research.

artículo científico publicado en 2015

How safe is acetaminophen for the treatment of pain and fever in newly-abstinent patients with alcoholism?

artículo científico publicado en 2008

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.

artículo científico publicado en 2016

Individuals with Primary Sclerosing Cholangitis Have Elevated Levels of Biomarkers for Apoptosis but Not Necrosis.

artículo científico publicado en 2015

Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study

artículo científico publicado en 2005

Isolated melanosis of the gastric antrum: an unusual endoscopic finding

scientific article published on 04 December 2006

Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid

scientific article published on 24 March 2020

Magic wand and crystal ball for primary sclerosing cholangitis

artículo científico publicado en 2014

Multicenter timolol study: the value of timolol and hemodynamic monitoring in the management of portal hypertensive cirrhotics with no esophageal varices

artículo científico publicado en 2006

Myths and mysteries about staging hepatic fibrosis by fibroscan

artículo científico publicado en 2014

Nodular Regenerative Hyperplasia After Treatment With Trastuzumab Emtansine

artículo científico publicado en 2014

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

artículo científico publicado en 2009

Oxidative Stress in Chronic Liver Disease: Relationship Between Peripheral and Hepatic Measurements ⬇️

artículo científico publicado el 1 de octubre de 2011

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

artículo científico publicado en 2005

Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients ⬇️

artículo científico publicado el 1 de agosto de 2013

Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease ⬇️

artículo científico publicado el 21 de diciembre de 2010

Prevalence and morbidity associated with muscle cramps in patients with cirrhosis.

artículo científico publicado en 2012

Randomized Controlled Trial of a Leucine-Metformin-Sildenafil Combination (NS-0200) on Weight and Metabolic Parameters

artículo científico publicado en 2019

Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin

artículo científico publicado en 2012

Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples

scientific article published on 01 February 2007

Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease

artículo científico publicado en 2014

Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.

artículo científico publicado en 2013

Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis

artículo científico publicado en 2013

Reply: To PMID 24395623

artículo científico publicado en 2015

Reply: To PMID 24395623

artículo científico publicado en 2015

Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide

artículo científico publicado en 2006

Screening Strategies for Nonalcoholic Steatohepatitis in High-Risk Individuals: Trimming Away the Fat

artículo científico publicado en 2016

Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials

scientific article published on 05 March 2020

Serum concentration-dependent hepatotoxicity in individuals receiving oral salsalate.

artículo científico publicado en 2008

Serum hepcidin levels are associated with obesity but not liver disease.

artículo científico publicado en 2013

Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.

artículo científico publicado en 2014

Serum proteomic profiling in patients with drug-induced liver injury.

artículo científico publicado en 2012

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

artículo científico publicado en 2010

Severe drug-induced skin and liver injury from rivaroxaban

artículo científico publicado en 2015

Statins for hyperlipidemia in patients with chronic liver disease: are they safe?

artículo científico publicado en 2006

Steatosis and liver stiffness measurements using transient elastography

artículo científico publicado en 2016

The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites.

artículo científico publicado en 2010

Therapeutic doses of acetaminophen frequently cause elevated aminotransferases in healthy volunteers: is it significant?

scientific article published on 01 April 2007

Treatment of acute portal vein thrombosis by nontraditional anticoagulation.

artículo científico publicado en 2014

Use of statins in patients with liver disease.

artículo científico publicado en 2009

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2018

When Enough Is Not Enough: Screening, Brief Intervention and Referral to Treatment for Hepatitis C in Patients Presenting to the Emergency Department

artículo científico publicado en 2018

Lista de obras de Raj Vuppalanchi

A not-so-sweet diagnosis: secondary biliary cirrhosis from a "lollipop" stone

A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis

Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity

Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.

Clinical and histologic features of azithromycin-induced liver injury

Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide

Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Non-alcoholic Fatty Liver Disease Based on United States Health Care System

De novo malignancy post-liver transplantation: a single center, population controlled study.

Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage

Drug-Induced Liver Injury.

Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt

Drug-induced nodular regenerative hyperplasia.

Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.

Dyslipidemia in patients with nonalcoholic fatty liver disease.

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

Endoscopic Sedation in Roux-en-Y Gastric Bypass

Endoscopic therapy with 2-octyl-cyanoacrylate for the treatment of gastric varices.

Erratum to: Severe Drug-Induced Skin and Liver Injury from Rivaroxaban

Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.

Febuxostat-induced acute liver injury.

Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease

HIV-1 coinfection profoundly alters intrahepatic chemokine but not inflammatory cytokine profiles in HCV-infected subjects

HLA-B*35:01 and Green Tea Induced Liver Injury

Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.

Herbal dietary supplement associated hepatotoxicity: an upcoming workshop and need for research.

How safe is acetaminophen for the treatment of pain and fever in newly-abstinent patients with alcoholism?

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.

Individuals with Primary Sclerosing Cholangitis Have Elevated Levels of Biomarkers for Apoptosis but Not Necrosis.

Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study

Isolated melanosis of the gastric antrum: an unusual endoscopic finding

Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid

Magic wand and crystal ball for primary sclerosing cholangitis

Multicenter timolol study: the value of timolol and hemodynamic monitoring in the management of portal hypertensive cirrhotics with no esophageal varices

Myths and mysteries about staging hepatic fibrosis by fibroscan

Nodular Regenerative Hyperplasia After Treatment With Trastuzumab Emtansine

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

Oxidative Stress in Chronic Liver Disease: Relationship Between Peripheral and Hepatic Measurements ⬇️

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients ⬇️

Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease ⬇️

Prevalence and morbidity associated with muscle cramps in patients with cirrhosis.

Randomized Controlled Trial of a Leucine-Metformin-Sildenafil Combination (NS-0200) on Weight and Metabolic Parameters

Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin

Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples

Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease

Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.

Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis

Reply: To PMID 24395623

Reply: To PMID 24395623

Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide

Screening Strategies for Nonalcoholic Steatohepatitis in High-Risk Individuals: Trimming Away the Fat

Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials

Serum concentration-dependent hepatotoxicity in individuals receiving oral salsalate.

Serum hepcidin levels are associated with obesity but not liver disease.

Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.

Serum proteomic profiling in patients with drug-induced liver injury.

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

Severe drug-induced skin and liver injury from rivaroxaban

Statins for hyperlipidemia in patients with chronic liver disease: are they safe?

Steatosis and liver stiffness measurements using transient elastography

The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites.

Therapeutic doses of acetaminophen frequently cause elevated aminotransferases in healthy volunteers: is it significant?

Treatment of acute portal vein thrombosis by nontraditional anticoagulation.

Use of statins in patients with liver disease.

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

When Enough Is Not Enough: Screening, Brief Intervention and Referral to Treatment for Hepatitis C in Patients Presenting to the Emergency Department